Table 9 Aggregated payments – company-level data reported by companies following the ABPI Code (2018)
Company name recorded in Disclosure UK | Standardised international name recorded on drug company website | Value of aggregated payments, ($) | Aggregated payments—share of all payments, (%) | Value of aggregated non-R&D payments to HCOs and HCPs ($) | Aggregated non-R&D payments—share of all payments | Aggregated non-R&D payments—share of aggregated payments | Value of aggregated HCPs payments ($) | Aggregated HCPs payments – share of payments to HCPs | Aggregated HCPs payments – share of aggregated non-R&D payments to HCPs and HCOs | Value of R&D payments ($) | R&D—share of all payments | R&D—share of all undisclosed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Martindale Pharma | Martindale Pharma | 10,224.80 | 100.00% | 10,224.80 | 100.00% | 100.00% | 10,224.80 | 100.00% | 100.00% | Â | 0.00% | 0.00% |
Avexis EU Ltd | Avexis EU | 5,121.90 | 100.00% | 5,121.90 | 100.00% | 100.00% | 5,121.90 | 100.00% | 100.00% | Â | 0.00% | 0.00% |
Clinuvel (UK) Ltd | Clinuvel | 1,367.10 | 100.00% | Â | 0.00% | 0.00% | Â | N/A | N/A | 1,367.10 | 100.00% | 100.00% |
Biotest UK | Biotest | 9,585,976.60 | 99.60% | 28,135.10 | 0.30% | 0.30% | 28,135.10 | 77.00% | 100.00% | 9,557,841.50 | 99.30% | 99.70% |
Clovis Oncology UK Ltd | Clovis Oncology | 975,763.80 | 99.40% | 225,033.50 | 22.90% | 23.10% | 225,033.50 | 97.40% | 100.00% | 750,730 | 76.50% | 76.90% |
Bluebird Bio UK Limited | Bluebird Bio | 1,046,010.10 | 98.30% | Â | 0.00% | 0.00% | Â | 0.00% | N/A | 1,046,010 | 98.30% | 100.00% |
Sunovion Pharmaceuticals Europe Ltd | Sunovion Pharmaceuticals Europe | 997,565.00 | 97.80% | 348,327.50 | 34.20% | 34.90% | 348,327.50 | 100.00% | 100.00% | 649,237 | 63.70% | 65.10% |
Allergan Ltd | Allergan | 36,889,921.10 | 97.40% | 935,807.80 | 2.50% | 2.50% | 935,807.80 | 70.30% | 100.00% | 35,954,113.30 | 95.00% | 97.50% |
Eisai Ltd | Eisai | 5,838,665.00 | 96.10% | 176,061.60 | 2.90% | 3.00% | 176,061.60 | 60.90% | 100.00% | 5,662,603.30 | 93.20% | 97.00% |
Indivior UK Ltd | Indivior | 865,474.10 | 96.10% | 74,798.90 | 8.30% | 8.60% | 74,798.90 | 80.20% | 100.00% | 790,675 | 87.80% | 91.40% |
Tesaro UK Ltd | Tesaro | 916,484.40 | 95.70% | 136,050.50 | 14.20% | 14.80% | 136,050.50 | 100.00% | 100.00% | 780,434 | 81.50% | 85.20% |
Otsuka Pharmaceuticals UK Ltd | Otsuka Pharmaceuticals | 2,223,454.80 | 95.20% | 186,453.80 | 8.00% | 8.40% | 186,453.80 | 80.60% | 100.00% | 2,037,001.00 | 87.20% | 91.60% |
AstraZeneca | AstraZeneca | 64,712,032.10 | 94.60% | 1,364,300.20 | 2.00% | 2.10% | 1,364,300.20 | 47.10% | 100.00% | 63,347,731.90 | 92.60% | 97.90% |
Alcon UK Ltd | Alcon | 1,300,368.30 | 94.50% | 498,527.60 | 36.20% | 38.30% | 498,527.60 | 100.00% | 100.00% | 801,840.70 | 58.30% | 61.70% |
Bristol-Myers Squibb Pharmaceuticals Ltd | Bristol-Myers Squibb | 43,015,683.90 | 94.20% | 682,542.40 | 1.50% | 1.60% | 682,542.40 | 46.70% | 100.00% | 42,333,141.50 | 92.70% | 98.40% |
Servier Laboratories Ltd | Servier Laboratories | 9,416,038.10 | 94.10% | 548,154.30 | 5.50% | 5.80% | 548,154.30 | 73.00% | 100.00% | 8,867,883.80 | 88.60% | 94.20% |
Celgene Ltd | Celgene | 20,684,739 | 92.80% | 107,653 | 0.50% | 0.50% | 107,653 | 12.90% | 100.00% | 20,577,086 | 92.40% | 99.50% |
Diurnal | Diurnal | 2,166,212 | 92.70% | Â | 0.00% | 0.00% | Â | 0.00% | N/A | 2,166,212 | 92.70% | 100.00% |
GW Pharmaceuticals plc | GW Pharmaceuticals | 1,143,354.20 | 91.80% | 7,797.40 | 0.60% | 0.70% | 7,797.40 | 14.10% | 100.00% | 1,135,556.80 | 91.20% | 99.30% |
Akcea Therapeutics UK | Akcea Therapeutics | 266,954.30 | 90.90% | 34,389.60 | 11.70% | 12.90% | 34,389.60 | 56.20% | 100.00% | 232,565 | 79.20% | 87.10% |
Syner-med | Syner-Med | 57,872.30 | 90.10% | Â | 0.00% | 0.00% | Â | N/A | N/A | 57,872 | 90.10% | 100.00% |
Takeda UK Ltd | Takeda | 12,866,306.90 | 88.40% | 481,291.60 | 3.30% | 3.70% | 481,291.60 | 100.00% | 100.00% | 12,385,015.30 | 85.10% | 96.30% |
Octapharma Ltd | Octapharma | 706,412.60 | 87.70% | 59,525.40 | 7.40% | 8.40% | 59,525.40 | 72.90% | 100.00% | 646,887 | 80.30% | 91.60% |
Roche Products Limited | Roche | 32,860,281.40 | 87.60% | 1,302,844.20 | 3.50% | 4.00% | 1,302,844.20 | 43.40% | 100.00% | 31,557,437.10 | 84.20% | 96.00% |
Merz Pharma UK Ltd | Merz Pharma | 3,809,689.40 | 85.70% | 514,001.80 | 11.60% | 13.50% | 514,001.80 | 55.30% | 100.00% | 3,295,687.60 | 74.10% | 86.50% |
Janssen-Cilag Ltd | Janssen Pharmaceuticals | 28,864,738.90 | 84.40% | 1,707,603.50 | 5.00% | 5.90% | 1,707,603.50 | 55.20% | 100.00% | 27,157,135.40 | 79.40% | 94.10% |
Biogen Idec Ltd | Biogen | 17,022,394.10 | 83.90% | 534,532.30 | 2.60% | 3.10% | 534,532.30 | 72.10% | 100.00% | 16,487,861.80 | 81.30% | 96.90% |
Shionogi Limited | Shionogi | 223,033.00 | 83.70% | 44,076.60 | 16.50% | 19.80% | 44,076.60 | 100.00% | 100.00% | 178,956 | 67.20% | 80.20% |
Merck Sharp & Dohme Ltd | Merck Sharp & Dohme | 27,875,141.40 | 83.30% | 78,327.80 | 0.20% | 0.30% | 78,327.80 | 3.70% | 100.00% | 27,796,813.70 | 83.10% | 99.70% |
Shire Pharmaceuticals Ltd | Shire Pharmaceuticals | 3,533,626.60 | 80.60% | 595,532.80 | 13.60% | 16.90% | 595,532.80 | 100.00% | 100.00% | 2,938,093.80 | 67.10% | 83.10% |
Pharmasure Ltd | Pharmasure | 188,530.60 | 80.30% | 71,118.00 | 30.30% | 37.70% | 71,118.00 | 100.00% | 100.00% | 117,413 | 50.00% | 62.30% |
Pharma Mar SA | PharmaMar | 123,647.10 | 80.30% | 9,384.20 | 6.10% | 7.60% | 9,384.20 | 40.70% | 100.00% | 114,263 | 74.20% | 92.40% |
Amicus Therapeutics | Amicus Therapeutics | 213,547.90 | 80.10% | 105,430.20 | 39.50% | 49.40% | 105,430.20 | 70.30% | 100.00% | 108,118 | 40.50% | 50.60% |
PTC Therapeutics Limited | PTC Therapeutics | 821,220.80 | 79.70% | 19,591.00 | 1.90% | 2.40% | 19,591.00 | 22.10% | 100.00% | 801,630 | 77.80% | 97.60% |
LEO Laboratories Ltd | LEO Pharma | 2,138,828.80 | 79.00% | 429,337.00 | 15.90% | 20.10% | 429,337.00 | 80.80% | 100.00% | 1,709,491.80 | 63.20% | 79.90% |
Astellas Pharma Ltd | Astellas Pharma | 2,435,505.40 | 78.70% | 94,330.90 | 3.00% | 3.90% | 94,330.90 | 44.50% | 100.00% | 2,341,174.60 | 75.70% | 96.10% |
Bayer Plc | Bayer | 31,660,582.20 | 78.50% | 1,961,751.60 | 4.90% | 6.20% | 1,961,751.60 | 49.70% | 100.00% | 29,698,830.60 | 73.60% | 93.80% |
Mitsubishi Tanabe Pharma Europe Ltd | Mitsubishi Tanabe Pharma | 619,928.00 | 78.30% | Â | 0.00% | 0.00% | Â | 0.00% | N/A | 619,928 | 78.30% | 100.00% |
Bial Pharma UK Ltd | Bial Pharma | 530,965.80 | 78.00% | 32,811.70 | 4.80% | 6.20% | 32,811.70 | 18.80% | 100.00% | 498,154 | 73.20% | 93.80% |
Alimera Sciences Limited | Alimera Sciences | 167,083.00 | 77.80% | 28,539.50 | 13.30% | 17.10% | 28,539.50 | 69.50% | 100.00% | 138,543 | 64.50% | 82.90% |
Intercept Pharma | Intercept Pharma | 740,818.70 | 77.70% | 15,623.30 | 1.60% | 2.10% | 15,623.30 | 47.20% | 100.00% | 725,195 | 76.10% | 97.90% |
Eli Lilly & Company Ltd | Eli Lilly | 8,954,564.90 | 77.50% | 1,260,978.70 | 10.90% | 14.10% | 1,260,978.70 | 56.10% | 100.00% | 7,693,586.20 | 66.50% | 85.90% |
Boehringer Ingelheim Ltd | Boehringer Ingelheim | 6,504,936.90 | 77.20% | 1,189,117.10 | 14.10% | 18.30% | 1,189,117.10 | 61.40% | 100.00% | 5,315,819.80 | 63.10% | 81.70% |
AbbVie Limited | AbbVie | 15,016,637.00 | 75.80% | 1,105,735.20 | 5.60% | 7.40% | 1,105,735.20 | 32.30% | 100.00% | 13,910,901.70 | 70.20% | 92.60% |
Santen UK Limited | Santen Pharmaceutical | 2,277,818.70 | 75.00% | 123,464.50 | 4.10% | 5.40% | 123,464.50 | 37.10% | 100.00% | 2,154,354.20 | 70.90% | 94.60% |
Jazz Pharma | Jazz Pharmaceuticals | 672,669.40 | 74.70% | 251,931.40 | 28.00% | 37.50% | 251,931.40 | 80.20% | 100.00% | 420,738 | 46.70% | 62.50% |
Alexion Pharma UK Ltd | Alexion Pharmaceuticals | 819,412.00 | 73.40% | 616,953.00 | 55.30% | 75.30% | 616,953.00 | 93.10% | 100.00% | 202,459 | 18.10% | 24.70% |
Daiichi Sankyo UK Ltd | Daiichi Sankyo | 1,390,606.60 | 72.50% | 53,465.40 | 2.80% | 3.80% | 53,465.40 | 14.30% | 100.00% | 1,337,141.30 | 69.70% | 96.20% |
Almirall Ltd | Almirall | 1,134,393.40 | 72.40% | 345,675.70 | 22.00% | 30.50% | 345,675.70 | 77.30% | 100.00% | 788,717.70 | 50.30% | 69.50% |
Merck Serono Ltd | Merck Serono | 4,205,087.10 | 71.40% | 665,812.60 | 11.30% | 15.80% | 665,812.60 | 53.50% | 100.00% | 3,539,274.60 | 60.10% | 84.20% |
BioMarin Europe Ltd | BioMarin Pharmaceutical | 3,118,921.30 | 71.00% | 93,463.50 | 2.10% | 3.00% | 46,291.70 | 8.60% | 49.50% | 3,025,457.80 | 68.90% | 97.00% |
IQVIA IES UK Limited | IQVIA | 23,373.00 | 70.00% | 23,373.00 | 70.00% | 100.00% | 23,373.00 | 70.00% | 100.00% | Â | 0.00% | 0.00% |
Novo Nordisk Limited | Novo Nordisk | 9,570,827.10 | 69.50% | 1,142,592.40 | 8.30% | 11.90% | 1,142,592.40 | 45.30% | 100.00% | 8,428,234.60 | 61.20% | 88.10% |
Dr Falk Pharma UK Ltd | Dr Falk Pharma | 155,851.20 | 69.10% | 155,851.20 | 69.10% | 100.00% | 155,851.20 | 70.40% | 100.00% | Â | 0.00% | 0.00% |
Ever Pharma UK Ltd | EVER Pharma | 13,770.00 | 68.90% | 13,770.00 | 68.90% | 100.00% | 13,770.00 | 68.90% | 100.00% | Â | 0.00% | 0.00% |
Leadiant Biosciences Limited | Leadiant Biosciences | 64,093.20 | 68.30% | 3,189.80 | 3.40% | 5.00% | 3,189.80 | 21.40% | 100.00% | 60,903 | 64.90% | 95.00% |
ApoPharma Inc | ApoPharma | 117,871.70 | 66.60% | Â | 0.00% | 0.00% | Â | 0.00% | N/A | 117,872 | 66.60% | 100.00% |
Sandoz Ltd | Sandoz | 1,672,523.40 | 64.80% | 15,926.50 | 0.60% | 1.00% | 15,926.50 | 5.10% | 100.00% | 1,656,596.90 | 64.10% | 99.00% |
Amgen Ltd | Amgen | 6,676,709.70 | 62.00% | 216,333.20 | 2.00% | 3.20% | 216,333.20 | 20.70% | 100.00% | 6,460,376.40 | 60.00% | 96.80% |
Novartis Pharmaceuticals UK Ltd | Novartis | 18,771,370.10 | 61.90% | 688,181.20 | 2.30% | 3.70% | 688,181.20 | 15.10% | 100.00% | 18,083,188.90 | 59.60% | 96.30% |
Profile Pharma Ltd | Profile Pharma | 832,647.10 | 60.30% | 31,287.10 | 2.30% | 3.80% | 31,287.10 | 56.50% | 100.00% | 801,360 | 58.00% | 96.20% |
Pfizer Ltd | Pfizer | 23,184,710.00 | 60.20% | 84,336.10 | 0.20% | 0.40% | 84,336.10 | 1.70% | 100.00% | 23,100,373.80 | 60.00% | 99.60% |
GlaxoSmithKline plc | GlaxoSmithKline | 22,745,157.20 | 59.50% | Â | 0.00% | 0.00% | Â | 0.00% | N/A | 22,745,157.20 | 59.50% | 100.00% |
Gilead | Gilead | 6,505,440.80 | 58.50% | 1,212,679.50 | 10.90% | 18.60% | 1,212,679.50 | 70.20% | 100.00% | 5,292,761.30 | 47.60% | 81.40% |
Sanofi Aventis | Sanofi | 8,015,216.90 | 57.20% | 1,354,442.30 | 9.70% | 16.90% | 1,354,442.30 | 46.70% | 100.00% | 6,660,774.60 | 47.60% | 83.10% |
Recordati Pharmaceuticals Ltd | Recordati Pharmaceuticals | 46,194.60 | 56.30% | 46,194.60 | 56.30% | 100.00% | 46,194.60 | 57.20% | 100.00% | Â | 0.00% | 0.00% |
Mundipharma International Limited | Mundipharma | 146,645.70 | 54.70% | 146,645.70 | 54.70% | 100.00% | 146,645.70 | 77.50% | 100.00% | Â | 0.00% | 0.00% |
Bausch & Lomb UK Ltd | Bausch + Lomb | 93,492.00 | 54.50% |  | 0.00% | 0.00% |  | 0.00% | N/A | 93,492 | 54.50% | 100.00% |
Teva UK Limited | Teva | 2,342,104.30 | 54.10% | 136,427.60 | 3.20% | 5.80% | 136,427.60 | 100.00% | 100.00% | 2,205,676.70 | 50.90% | 94.20% |
Concordia International Rx UK Ltd | Concordia International | 64,728.20 | 51.30% | 24,762.00 | 19.60% | 38.30% | 24,762.00 | 98.10% | 100.00% | 39,966 | 31.70% | 61.70% |
HRA Pharma UK & Ireland Ltd | HRA Pharma | 95,128.00 | 50.00% | Â | 0.00% | 0.00% | Â | 0.00% | N/A | 95,128 | 50.00% | 100.00% |
Aguettant Ltd | Aguettant | 21,565.70 | 47.40% | 21,565.70 | 47.40% | 100.00% | 21,565.70 | 50.00% | 100.00% | Â | 0.00% | 0.00% |
Actelion Pharmaceuticals UK Ltd | Actelion Pharmaceuticals | 849,107.70 | 45.10% | 535,930.70 | 28.40% | 63.10% | 535,930.70 | 82.90% | 100.00% | 313,177 | 16.60% | 36.90% |
Ipsen Developments Ltd | Ipsen | 299,426.90 | 44.10% | 110,836.70 | 16.30% | 37.00% | 110,836.70 | 32.60% | 100.00% | 188,590 | 27.80% | 63.00% |
A. Menarini Farmaceutica Internazionale S.r.l | A. Menarini Farmaceutica Internazionale | 128,098.00 | 44.10% | 94,690.70 | 32.60% | 73.90% | 94,690.70 | 50.30% | 100.00% | 33,407 | 11.50% | 26.10% |
Grunenthal Ltd | Grunenthal | 262,966.20 | 41.60% | 107,925.20 | 17.10% | 41.00% | 107,925.20 | 49.60% | 100.00% | 155,041 | 24.50% | 59.00% |
Britannia Pharmaceuticals | Britannia Pharmaceuticals | 74,980.50 | 39.80% | 74,833.00 | 39.70% | 99.80% | 74,833.00 | 86.00% | 100.00% | 147 | 0.10% | 0.20% |
Guerbet Laboratories Ltd | Guerbet Laboratories | 103,659.40 | 39.50% | 31,494.20 | 12.00% | 30.40% | 31,494.20 | 64.90% | 100.00% | 72,165 | 27.50% | 69.60% |
Alnylam Pharmaceuticals UK & Ireland | Alnylam Pharmaceuticals | 426,896.40 | 38.60% | 92,292.60 | 8.40% | 21.60% | 92,292.60 | 57.90% | 100.00% | 334,604 | 30.30% | 78.40% |
Accretio | Accretio | 794.7 | 35.60% | 794.7 | 35.60% | 100.00% | 794.7 | 100.00% | 100.00% | Â | 0.00% | 0.00% |
Chugai Pharma UK | Chugai Pharmaceutical | 217,303.10 | 35.40% | 88,239.20 | 14.40% | 40.60% | 88,239.20 | 45.10% | 100.00% | 129,064 | 21.00% | 59.40% |
Dermal | Dermal Laboratories | 72,110.20 | 34.50% | 17,527.10 | 8.40% | 24.30% | 17,527.10 | 13.60% | 100.00% | 54,583 | 26.10% | 75.70% |
Gedeon Richter (UK) Ltd | Gedeon Richter | 114,012.80 | 33.00% | 114,012.80 | 33.00% | 100.00% | 114,012.80 | 80.20% | 100.00% | Â | 0.00% | 0.00% |
GE Healthcare Limited | GE Healthcare | 201,164.10 | 32.60% | 152,954.20 | 24.80% | 76.00% | 152,954.20 | 100.00% | 100.00% | 48,210 | 7.80% | 24.00% |
CSL Behring | CSL Behring | 222,579.20 | 31.50% | 118,769.70 | 16.80% | 53.40% | 118,769.70 | 32.10% | 100.00% | 103,810 | 14.70% | 46.60% |
Lundbeck Ltd | Lundbeck | 248,286.50 | 31.40% | 86,423.80 | 10.90% | 34.80% | 86,423.80 | 16.00% | 100.00% | 161,863 | 20.50% | 65.20% |
Chiesi Ltd | Chiesi | 2,032,217.40 | 28.70% | 628,223.90 | 8.90% | 30.90% | 628,223.90 | 45.60% | 100.00% | 1,403,993.40 | 19.80% | 69.10% |
Besins Healthcare (UK) Ltd | Besins Healthcare | 99,987.00 | 27.70% | 99,987.00 | 27.70% | 100.00% | 99,987.00 | 87.00% | 100.00% | Â | 0.00% | 0.00% |
Napp Pharmaceuticals Ltd | Napp Pharmaceuticals | 774,726.20 | 24.40% | 774,726.20 | 24.40% | 100.00% | 774,726.20 | 62.80% | 100.00% | Â | 0.00% | 0.00% |
Fresenius-Kabi Ltd | Fresenius Kabi | 48,412.80 | 23.90% | 48,412.80 | 23.90% | 100.00% | 48,412.80 | 23.90% | 100.00% | Â | 0.00% | 0.00% |
Norgine | Norgine | 66,774.70 | 20.50% | 33,266.10 | 10.20% | 49.80% | 33,266.10 | 18.40% | 100.00% | 33,509 | 10.30% | 50.20% |
Fresenius Medical Care (UK) Ltd | Fresenius Medical Care | 20,644.90 | 20.20% | 20,644.90 | 20.20% | 100.00% | 20,644.90 | 46.80% | 100.00% | Â | 0.00% | 0.00% |
Orion Pharma (UK) Ltd | Orion Pharma | 95,822.50 | 16.10% | 5,845.40 | 1.00% | 6.10% | 5,845.40 | 26.10% | 100.00% | 89,977 | 15.10% | 93.90% |
Proveca Ltd | Proveca | 7,116.20 | 14.10% | 7,116.20 | 14.10% | 100.00% | 7,116.20 | 100.00% | 100.00% | Â | 0.00% | 0.00% |
RB | Reckitt Benckiser | 5,947.80 | 13.80% | 2,436.10 | 5.70% | 41.00% | 2,436.10 | 6.20% | 100.00% | 3,511.70 | 8.20% | 59.00% |
Sobi Ltd | Sobi | 92,529.20 | 13.40% | 92,529.20 | 13.40% | 100.00% | 92,529.20 | 100.00% | 100.00% | Â | 0.00% | 0.00% |
ALK-Abello Ltd | ALK-Abello | 14,955.80 | 11.90% | 3,909.10 | 3.10% | 26.10% | 3,909.10 | 7.70% | 100.00% | 11,046.70 | 8.80% | 73.90% |
Ferring Pharma | Ferring Pharmaceuticals | 102,525.80 | 9.10% | 67,058.40 | 6.00% | 65.40% | 67,058.40 | 9.20% | 100.00% | 35,467 | 3.20% | 34.60% |
Orphan Europe UK Ltd | Orphan Europe | 1,714.90 | 6.40% | 1,714.90 | 6.40% | 100.00% | 1,714.90 | 50.00% | 100.00% | Â | 0.00% | 0.00% |
Consilient Health Ltd | Consilient Health | 19,993.20 | 6.10% | 19,993.20 | 6.10% | 100.00% | 19,993.20 | 32.70% | 100.00% | Â | 0.00% | 0.00% |
Aegerion Pharmaceuticals Limited | Aegerion Pharmaceuticals | 1,702.90 | 4.20% | 1,702.90 | 4.20% | 100.00% | 1,702.90 | 100.00% | 100.00% | Â | 0.00% | 0.00% |
Accord-UK Ltd | Accord Healthcare | 8,332.00 | 4.00% | 8,332.00 | 4.00% | 100.00% | 8,332.00 | 37.90% | 100.00% | Â | 0.00% | 0.00% |
Colonis Pharma Ltd | Colonis | 534.2 | 3.20% | 534.2 | 3.20% | 100.00% | 534.2 | 66.70% | 100.00% | Â | 0.00% | 0.00% |
Baxter Healthcare Ltd | Baxter Healthcare | 11,800.90 | 2.00% | 11,800.90 | 2.00% | 100.00% | 11,800.90 | 3.80% | 100.00% | Â | 0.00% | 0.00% |
Lincoln Medical | Lincoln Medical | 357.2 | 2.00% | 357.2 | 2.00% | 100.00% | 357.2 | 50.00% | 100.00% | Â | 0.00% | 0.00% |
Alliance Pharmaceuticals Ltd | Alliance Pharma | 2,285.20 | 1.70% | 2,285.20 | 1.70% | 100.00% | 2,285.20 | 18.80% | 100.00% | Â | 0.00% | 0.00% |
Pierre Fabre Ltd | Pierre Fabre | 1,202.00 | 1.40% | 1,202.00 | 1.40% | 100.00% | 1,202.00 | 2.70% | 100.00% | Â | 0.00% | 0.00% |
Flynn Pharma | Flynn Pharma | 4,101.60 | 1.30% | 2,231.10 | 0.70% | 54.40% | 2,231.10 | 1.70% | 100.00% | 1,870.50 | 0.60% | 45.60% |
Rosemont Pharmaceuticals Ltd | Rosemont Pharmaceuticals | 601 | 1.20% | 601 | 1.20% | 100.00% | 601 | 11.70% | 100.00% | Â | 0.00% | 0.00% |
Bracco UK Ltd | Bracco | 555.4 | 0.40% | 555.4 | 0.40% | 100.00% | 555.4 | 0.60% | 100.00% | Â | 0.00% | 0.00% |
Seqirus | Seqirus | 492.7 | 0.40% | 492.7 | 0.40% | 100.00% | 492.7 | 0.40% | 100.00% | Â | 0.00% | 0.00% |
Bio Products Laboratory Ltd | Bio Products Laboratory | Â | 0.00% | Â | 0.00% | N/A | Â | 0.00% | N/A | Â | 0.00% | N/A |
Galen Ltd | Galen | Â | 0.00% | Â | 0.00% | N/A | Â | 0.00% | N/A | Â | 0.00% | N/A |
PARI Medical Ltd | PARI Medical | Â | 0.00% | Â | 0.00% | N/A | Â | 0.00% | N/A | Â | 0.00% | N/A |
Shield TX UK Ltd | Shield Therapeutics | Â | 0.00% | Â | 0.00% | N/A | Â | 0.00% | N/A | Â | 0.00% | N/A |
STD Pharmaceutical Products Ltd | STD Pharmaceutical Products | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |
Stirling Anglian Pharmaceuticals Ltd | Stirling Anglian Pharmaceuticals | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |
Thea Pharmaceuticals Ltd | Thea Pharmaceuticals | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |
Tillotts Pharma UK Ltd | Tillotts Pharma | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |
UCB Pharma Ltd | UCB Pharma | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |
Veriton Pharma | Veriton Pharma | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |
Vifor Pharma Group | Vifor Pharma | Â | 0.00% | Â | 0.00% | N/A | Â | N/A | N/A | Â | 0.00% | N/A |